Expression of MHC class II, interleukin 2 receptor and CD45 antigens on tumour-associated T lymphocytes in colonic carcinoma
1989

Study of Immune Cells in Colonic Cancer

Sample size: 18 publication Evidence: low

Author Information

Author(s): M.N. Norazmi, A.W. Hohmann, J.M. Skinner, J. Bradley

Primary Institution: Flinders Medical Centre

Hypothesis

The study investigates the expression of T lymphocyte activation markers in tumor-associated T lymphocytes surrounding colonic carcinomas.

Conclusion

Most tumor-associated T lymphocytes in colonic carcinomas are likely activated and primed, with a notable absence of IL2R and HLA-DQ positive cells in late-stage tumors.

Supporting Evidence

  • T lymphocytes are the predominant mononuclear cell infiltrate in colonic carcinomas.
  • Most tumor-associated mononuclear cells were found to be T cells.
  • HLA-DR positive cells were present in high densities in 16 of the 18 cases studied.
  • IL2R positive T lymphocytes were present in low density in only four of the 18 cases.
  • Cells expressing the p180 antigen were present in all cases.

Takeaway

The study looked at immune cells in colon cancer and found that many of them are active, but some important markers are missing in advanced cases.

Methodology

The study used fresh frozen and paraffin-embedded tissue sections from patients, applying monoclonal antibodies to identify T lymphocyte activation markers.

Limitations

The sample size is small, particularly for stage D tumors, which limits the generalizability of the findings.

Participant Demographics

Patients with colonic carcinoma, including various tumor stages (A, B, C, D).

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication